Lymph node metastases in patients with cutaneous melanoma: Improvements in diagnosis by signal-enhanced color Doppler sonography

Melanoma Research

Volumn 14, Issue 4, 2004, Pages 269-276

  Schmid Wendtner, Monika Hildegard ^a,c   Dill Müller, Dorothee ^b   Baumert, Jens ^a   Wagner, Arnold ^b   Eberle, Julia ^a   Tilgen, Wolfgang ^b   Plewig, Gerd ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

Color Doppler sonography; Cutaneous melanoma; Lymph node metastasis; Reactive lymph node; Signal enhancement; Ultrasonography

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; EVALUATION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MALE; MELANOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; SIGNAL TRANSDUCTION; VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FIBROADENOMA; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; SKIN NEOPLASMS; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 4344589720     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cmr.0000138827.19161.8b     Document Type: Article

References (24)

1. Balch CM, Milton GW, Shaw HM, Soong SJ. Cutaneous melanoma - clinical management and treatment results worldwide, 2nd edn. Philadelphia PA: Lippincott Company; 1992.
2. Garbe C, Blum A. Epidemiology of cutaneous melanoma in Germany and worldwide. Skin Pharmacol Appl Skin Physiol 2001; 14:280-290.
3. Schmid-Wendtner MH, Baumert J, Schmidt M, Plewig G, Volkenandt M, Hölzel D. Prognostic index for cutaneous melanoma: an analysis after follow-up of 2715 patients. Melanoma Res 2001; 11:1-8.
4. Balch CM, Soong SJ, Murad TM, Smith JW, Maddox WA, Durant JR. A multifactorial analysis of melanoma: IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III). J Clin Oncol 1983; 1:126-134.
5. Balch CM. Cutaneous melanoma: prognosis and treatment results worldwide. Semin Surg Oncol 1992; 8:400-414.
6. Buzzell RA, Zitelli JA. Favorable prognostic factors in recurrent and metastatic melanoma. J Am Acad Dermatol 1996; 34:798-803.
7. Blum A, Schlagenhauff B, Stroebel W, Breuninger H, Rassner G, Garbe C. Ultrasound examination of regional lymph nodes significantly improves early detection of locoregional metastases during the follow-up of patients with cutaneous melanoma. Cancer 2000; 88:2534-2539.
8. Nazarian LN, Alexander AA, Rawool NM, Kurtz AB, Maguire HC, Mastrangelo MJ. Malignant melanoma: impact of superficial ultrasound on management. Radiology 1996; 199:273-277.
9. Schmid-Wendtner MH, Paerschke G, Baumert J, Plewig G, Volkenandt M. Value of ultrasonography and physical examination for detection of locoregional metastases in patients with cutaneous melanoma. Melanoma Res 2003; 13:183-188.
10. Moehrle M, Blum A, Rassner G, Juenger M. Lymph node metastases of cutaneous melanoma: diagnosis by B-scan and color Doppler sonography. J Am Acad Dermatol 1999; 41:703-709.
11. Schmid-Wendtner MH, Partscht K, Korting HC, Volkenandt M. Improved differentiation of benign and malignant lymphadenopathy in patients with cutaneous melanoma by contrast-enhanced color Doppler sonography. Arch Dermatol 2002; 138:491-497.
12. Garbe C, Paul A, Kohler-Späth H, Ellwanger U, Stroebel W, Schwarz M, et al. Prospective evaluation of a follow-up schedule in 2,008 patients with cutaneous melanoma: recommendations for an improved follow-up strategy. J Clin Oncol 2003; 121:520-529.
13. Solbiati L, Rizzatto G, Belotti E. High resolution sonography of cervical lymph nodes in head and neck cancer: criteria for differentiation of reactive versus malignant lymph nodes. Radiology 1988; 169:113.
14. Vassallo P, Wernecke K, Ross N, Peters PE. Differentiation of benign from malignant superficial lymphadenopathy: the role of high-resolution ultrasound. Radiology 1992; 183:215-220.
15. Tschammler A, Wirkner H, Ott G, Hahn D. Vascular pattern in reactive and malignant lymphadenopathy. Eur Radiol 1996; 6:473-480.
16. Schlief R, Schürman R, Niendorf HP. Basic properties and results of clinical trials of ultrasound contrast agents based on galactose. Ann Acad Med Singapore 1993; 22:762-767.
17. Ludwig A, Moritz JD, Kirchhoff L, Vollheim T, Wiese KG. New perspectives in head and neck sonography by signal-enhanced color Doppler sonography. Mund Kiefer GesichtsChir 1998; 2 (Suppl 1):S163-S167.
18. Schürmann R, Schlief R. Saccharide based contrast agents. Characteristics and diagnostic potential. Radiol Med Torino 1994; 87 (Suppl 1): 15-53.
19. Schwarz KQ, Bechar H, Schimpfky C, Vorwerk D, Bogdahn U, Schlief R. A study of the magnitude of Doppler enhancement with SH U 508 A in multiple vascular regions. Radiology 1994; 193:195-201.
20. Beissert M, Delorme S, Mutze S, Lees WR, Bahner ML, Filimonow S, et al. Comparison of B-mode and conventional colour/power Doppler ultrasound, contrast-enhanced Doppler ultrasound and spiral CT in the diagnosis of focal lesions of the liver: results of a multicenter study. Ultraschall in Med 2002; 23:245-250.
21. Tschammler A, Knitter J, Wittenberg G, Krahe T, Hahn D. Quantifizierung der Lymphknotenperfusion mittels farbkodierter Duplexsonographie. Röfo Fortschr Geh Röntgenstr Neuen Bildgeb Verfahren 1995; 163: 203-209.
22. Benzel W, Zenk J, Winter M, Iro H. Color Doppler ultrasound studies of benign and malignant lymph nodes. HNO 1996; 44:666-671.
23. Giovagnorio F, Caiazzo R, Avitto A. Evaluation of vascular patterns of cervical lymph nodes with power Doppler sonography. J Clin Ultrasound 1997; 25:71-76.
24. Nazarian LN, Alexander AA, Kurtz AB, Capuzzi DM, Rawool NM, Gilbert KR, Mastrangelo MJ. Superficial melanoma metastases: appearance on gray-scale and color-Doppler sonography. Am J Roentgenol 1998; 170: 459-463.